Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
about
Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention.Peptide Microarrays for Real-Time Kinetic Profiling of Tyrosine Phosphatase Activity of Recombinant Phosphatases and Phosphatases in Lysates of Cells or Tissue Samples.Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysisProtein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease
P2860
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
@en
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
@nl
type
label
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
@en
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
@nl
prefLabel
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
@en
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
@nl
P2093
P2860
P356
P1433
P1476
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis
@en
P2093
Wenjie Guo
Xuefeng Wu
P2860
P2888
P356
10.1038/SREP02845
P407
P577
2013-10-03T00:00:00Z